Get the latest tech news
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
With the news yesterday that “mini organs” have been grown for the first time using human stem cells, this futuristic area of bio-medicine is clearly With the news yesterday that “mini organs” have been grown for the first time using human stem cells, this futuristic area of bio-medicine is clearly accelerating by leaps and bounds. However, harvesting stem cells is a controversial process, since a major method involves harvesting during pregnancy. Now, a Swedish startup has raised VC investment to take a new process for generating stem cells, hailed as a revolutionary tool to alleviate and prevent a wide variety of medical conditions, to industrial-scale levels.
Now a Swedish startup has raised VC investment to take a new process for generating stem cells, hailed as a revolutionary tool to alleviate and prevent a wide variety of medical conditions, to industrial-scale levels. The news yesterday detailed how researchers at UCL and Great Ormond Street Hospital in London extracted stem cells that had passed into the amniotic fluid, which surrounds the child in the womb and protects it during pregnancy. Cellcolabs originated from the pioneering stem cell research of Professor Katarina Le Blanc at the world-renowned Karolinska Institute in Stockholm, most famous for inventing the pacemaker, mitochondrial medicine, and winning several Nobel prizes.
Or read this on TechCrunch